• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑郁症状学清单(IDS-C(28))比汉密尔顿抑郁评定量表(HAMD(17))在轻度、中度或亚综合征抑郁患者中更能敏感地反映抑郁症状学的变化。

The Inventory Of Depressive Symptomatology (IDS-C(28)) is more sensitive to changes in depressive symptomatology than the Hamilton Depression Rating Scale (HAMD(17)) in patients with mild major, minor or subsyndromal depression.

机构信息

Department of Psychiatry and Psychotherapy, University Medical Centre Mainz, Germany.

出版信息

Eur Arch Psychiatry Clin Neurosci. 2011 Aug;261(5):357-67. doi: 10.1007/s00406-010-0175-1. Epub 2010 Dec 4.

DOI:10.1007/s00406-010-0175-1
PMID:21132437
Abstract

Depression rating scales play a decisive role in the assessment of the severity of depression and the evaluation of the efficacy of antidepressant treatments. The Hamilton Depression Rating Scale (HAMD) is regarded as the 'gold standard'; nevertheless, studies suggest that the Inventory of Depressive Symptomatology (IDS) is more sensitive to detect symptom changes. The aim of the present study was to investigate whether the IDS is more sensitive in detecting changes in depression symptoms in patients with mild major, minor or subsyndromal depression (MIND). Biweekly IDS-C(28) and HAMD(17) data from 340 patients of a 10-week randomized, placebo-controlled trial comparing the effectiveness of sertraline and cognitive-behavioural therapy in patients with MIND were analysed. We investigated sensitivity to change for both scales (1) from assessment-to-assessment, (2) in relation to depression severity level, and (3) in relation to DSM-IV depression criterion symptoms. The IDS-C(28) was more sensitive in detecting changes in depression symptomatology over the treatment course as well as for different severity levels, especially in patients with a low depression severity. It assesses the DSM-IV criteria more thoroughly, is better able to track the change of cognitive symptoms and to identify residual symptoms. Both scales are well able to assess depressive symptomatology. However, the IDS-C(28) surpasses the HAMD(17) in detecting small changes especially in the core symptoms of depression. This is important for an optimal treatment by capturing early improvements, enabling prompt reactions and detecting residual symptoms.

摘要

抑郁评定量表在评估抑郁严重程度和评估抗抑郁治疗效果方面起着决定性作用。汉密尔顿抑郁评定量表(HAMD)被认为是“金标准”;然而,研究表明,抑郁症状量表(IDS)更能敏感地检测到症状变化。本研究旨在探讨 IDS 是否更能敏感地检测到轻度、中度或亚综合征性抑郁症(MIND)患者抑郁症状的变化。对 340 例接受为期 10 周的随机、安慰剂对照试验的患者进行了每隔两周的 IDS-C(28)和 HAMD(17)数据分析,该试验比较了舍曲林和认知行为疗法对 MIND 患者的疗效。我们从评估到评估(1)、与抑郁严重程度水平的关系(2)以及与 DSM-IV 抑郁标准症状的关系(3),调查了两种量表的变化敏感性。在治疗过程中以及在不同严重程度水平上,IDS-C(28)在检测抑郁症状变化方面更为敏感,尤其是在抑郁严重程度较低的患者中。它更全面地评估了 DSM-IV 标准,更能跟踪认知症状的变化,并能识别残留症状。两种量表都能很好地评估抑郁症状。然而,IDS-C(28)在检测特别是抑郁症核心症状的微小变化方面优于 HAMD(17)。这对于通过捕捉早期改善、能够快速反应和检测残留症状来实现最佳治疗非常重要。

相似文献

1
The Inventory Of Depressive Symptomatology (IDS-C(28)) is more sensitive to changes in depressive symptomatology than the Hamilton Depression Rating Scale (HAMD(17)) in patients with mild major, minor or subsyndromal depression.抑郁症状学清单(IDS-C(28))比汉密尔顿抑郁评定量表(HAMD(17))在轻度、中度或亚综合征抑郁患者中更能敏感地反映抑郁症状学的变化。
Eur Arch Psychiatry Clin Neurosci. 2011 Aug;261(5):357-67. doi: 10.1007/s00406-010-0175-1. Epub 2010 Dec 4.
2
Sensitivity to changes during antidepressant treatment: a comparison of unidimensional subscales of the Inventory of Depressive Symptomatology (IDS-C) and the Hamilton Depression Rating Scale (HAMD) in patients with mild major, minor or subsyndromal depression.抗抑郁治疗期间变化的敏感性:轻度、中度或亚综合征抑郁患者的抑郁症状评定量表(IDS-C)和汉密尔顿抑郁评定量表(HAMD)的一维子量表的比较。
Eur Arch Psychiatry Clin Neurosci. 2012 Jun;262(4):291-304. doi: 10.1007/s00406-011-0263-x. Epub 2011 Sep 30.
3
The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation.公共部门心境障碍患者的抑郁症状量表临床医生评定版(IDS-C)与自评版(IDS-SR)以及快速抑郁症状量表临床医生评定版(QIDS-C)与自评版(QIDS-SR):一项心理测量学评估
Psychol Med. 2004 Jan;34(1):73-82. doi: 10.1017/s0033291703001107.
4
Novel Augmentation Strategies in Major Depression.重度抑郁症的新型强化治疗策略
Dan Med J. 2017 Apr;64(4).
5
Acceptability, Tolerability, and Estimates of Putative Treatment Effects of Probiotics as Adjunctive Treatment in Patients With Depression: A Randomized Clinical Trial.益生菌作为辅助治疗抑郁症患者的附加治疗的可接受性、耐受性和推测治疗效果的估计:一项随机临床试验。
JAMA Psychiatry. 2023 Aug 1;80(8):842-847. doi: 10.1001/jamapsychiatry.2023.1817.
6
Treatment of atypical depression: post-hoc analysis of a randomized controlled study testing the efficacy of sertraline and cognitive behavioural therapy in mildly depressed outpatients.非典型抑郁症的治疗:一项测试舍曲林和认知行为疗法对轻度抑郁门诊患者疗效的随机对照研究的事后分析。
Eur Psychiatry. 2010 Dec;25(8):491-8. doi: 10.1016/j.eurpsy.2010.01.010. Epub 2010 Jun 8.
7
Has the symptom severity inclusion requirement narrowed the definition of major depressive disorder in antidepressant efficacy trials?在抗抑郁药疗效试验中,症状严重程度纳入标准是否缩小了重度抑郁症的定义范围?
J Affect Disord. 2017 Mar 15;211:60-64. doi: 10.1016/j.jad.2017.01.008. Epub 2017 Jan 4.
8
Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression.抑郁症中的焦虑症状:汉密尔顿焦虑量表在抑郁症患者中的条目性能评估
Depress Anxiety. 2008;25(12):1006-13. doi: 10.1002/da.20435.
9
Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression.早期改善是轻度、中度或亚综合征性抑郁症患者治疗结果的预测因素。
J Affect Disord. 2010 Jan;120(1-3):86-93. doi: 10.1016/j.jad.2009.04.014.
10
The Quick Inventory of Depressive Symptomatology-Self-report: a psychometric evaluation in patients with asthma and major depressive disorder.抑郁症状快速自评量表:哮喘合并重度抑郁症患者的心理测量学评估
Ann Allergy Asthma Immunol. 2008 May;100(5):433-8. doi: 10.1016/S1081-1206(10)60467-X.

引用本文的文献

1
Comparison and application of depression screening tools for adolescents: scale selection and clinical practice.青少年抑郁筛查工具的比较与应用:量表选择与临床实践
Child Adolesc Psychiatry Ment Health. 2025 May 9;19(1):53. doi: 10.1186/s13034-025-00908-2.
2
Application Effect of Laparoscopic Myomectomy and Comprehensive Rehabilitation Nursing on Patients with Uterine Fibroids.腹腔镜子宫肌瘤剔除术与综合康复护理对子宫肌瘤患者的应用效果。
Comput Math Methods Med. 2022 Sep 22;2022:4018803. doi: 10.1155/2022/4018803. eCollection 2022.
3
Vasopressin Surrogate Marker Copeptin as a Potential Novel Endocrine Biomarker for Antidepressant Treatment Response in Major Depression: A Pilot Study.

本文引用的文献

1
Standardized rater training for the Hamilton Depression Rating Scale (HAMD₁₇) and the Inventory of Depressive Symptoms (IDS(C30)).针对汉密尔顿抑郁评定量表(HAMD₁₇)和抑郁症状量表(IDS(C30))的标准化评分者培训。
Psychopathology. 2011;44(1):68-70. doi: 10.1159/000318162. Epub 2010 Nov 11.
2
Responsiveness of observer rating scales by analysis of number of days until improvement in patients with major depression.通过分析重度抑郁症患者改善所需的天数来评估观察量表的反应性。
Eur Psychiatry. 1998 May;13(3):143-5. doi: 10.1016/S0924-9338(98)80138-7.
3
Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine.
血管加压素替代标志物 copeptin 作为重度抑郁症抗抑郁治疗反应潜在的新型内分泌生物标志物:一项初步研究。
Front Psychiatry. 2020 May 20;11:453. doi: 10.3389/fpsyt.2020.00453. eCollection 2020.
4
Clinical evaluation of deep brain stimulation of nucleus accumbens/anterior limb of internal capsule for opioid relapse prevention: protocol of a multicentre, prospective and double-blinded study.伏隔核/内囊前肢深部脑刺激预防阿片类药物复吸的临床评估:一项多中心、前瞻性、双盲研究方案。
BMJ Open. 2019 Feb 13;9(2):e023516. doi: 10.1136/bmjopen-2018-023516.
5
Comparative responsiveness of generic versus disorder-specific instruments for depression: An assessment in three longitudinal datasets.通用与疾病特异性量表评估抑郁的反应度比较:三项纵向数据集评估。
Depress Anxiety. 2019 Jan;36(1):93-102. doi: 10.1002/da.22809. Epub 2018 Sep 6.
6
Bright light therapy versus physical exercise to prevent co-morbid depression and obesity in adolescents and young adults with attention-deficit / hyperactivity disorder: study protocol for a randomized controlled trial.明亮光疗法与体育锻炼预防注意力缺陷/多动障碍青少年和青年共病抑郁和肥胖:一项随机对照试验的研究方案
Trials. 2018 Feb 26;19(1):140. doi: 10.1186/s13063-017-2426-1.
7
Convergence in patient-therapist therapeutic alliance ratings and its relation to outcome in chronic depression treatment.患者与治疗师在治疗联盟评分上的一致性及其与慢性抑郁症治疗结果的关系。
Psychother Res. 2017 Jul;27(4):410-424. doi: 10.1080/10503307.2015.1114687. Epub 2016 Feb 1.
8
Valence and agency influence striatal response to feedback in patients with major depressive disorder.效价和能动性影响重度抑郁症患者纹状体对反馈的反应。
J Psychiatry Neurosci. 2015 Nov;40(6):394-400. doi: 10.1503/jpn.140225.
9
Prefrontal thinning affects functional connectivity and regional homogeneity of the anterior cingulate cortex in depression.前额叶变薄影响抑郁症患者前扣带回皮质的功能连接性和局部一致性。
Neuropsychopharmacology. 2015 Jun;40(7):1640-8. doi: 10.1038/npp.2015.8. Epub 2015 Jan 19.
10
Using problem solving therapy to treat veterans with subsyndromal depression: a pilot study.使用问题解决疗法治疗亚综合征性抑郁症退伍军人:一项试点研究。
Int J Geriatr Psychiatry. 2014 Dec;29(12):1255-61. doi: 10.1002/gps.4105. Epub 2014 May 1.
伴有选择性 5-羟色胺再摄取抑制剂氟西汀的重度抑郁症患者在继续/维持治疗阶段的残留症状类型和复发风险。
Eur Arch Psychiatry Clin Neurosci. 2010 Mar;260(2):145-50. doi: 10.1007/s00406-009-0031-3. Epub 2009 Jul 2.
4
Effects of pharmacotherapy and psychotherapy in depressed primary-care patients: a randomized, controlled trial including a patients' choice arm.药物治疗和心理治疗对初级保健患者中抑郁的影响:一项随机对照试验,包括患者选择臂。
Int J Neuropsychopharmacol. 2010 Feb;13(1):31-44. doi: 10.1017/S1461145709000224. Epub 2009 Apr 3.
5
Clinical features and functioning of patients with minor depression.轻度抑郁症患者的临床特征与功能状况
Psychother Psychosom. 2008;77(6):384-9. doi: 10.1159/000151519. Epub 2008 Aug 21.
6
The Inventory of Depressive Symptomatology: German translation and psychometric validation.抑郁症状量表:德语翻译及心理测量学验证
Int J Methods Psychiatr Res. 2007;16(4):230-6. doi: 10.1002/mpr.226.
7
Development and reliability of the HAM-D/MADRS interview: an integrated depression symptom rating scale.汉密尔顿抑郁量表/蒙哥马利-艾森伯格抑郁评定量表访谈的开发与信度:一种综合抑郁症状评定量表
Psychiatry Res. 2006 Nov 29;145(1):21-37. doi: 10.1016/j.psychres.2005.10.009. Epub 2006 Oct 16.
8
Comparison of self-report and clinician ratings on two inventories of depressive symptomatology.关于两份抑郁症状量表的自我报告与临床医生评分的比较。
Psychiatr Serv. 2006 Jun;57(6):829-37. doi: 10.1176/ps.2006.57.6.829.
9
Multiple measures, methods, and moments: a factor-analytic investigation of change in depressive symptoms during acute-phase cognitive therapy for depression.多种测量方法、手段及时间点:对抑郁症急性期认知疗法中抑郁症状变化的因素分析调查
Psychol Med. 2005 May;35(5):693-704. doi: 10.1017/s0033291704004143.
10
The Hamilton Depression Rating Scale: has the gold standard become a lead weight?汉密尔顿抑郁评定量表:金标准是否已成为沉重负担?
Am J Psychiatry. 2004 Dec;161(12):2163-77. doi: 10.1176/appi.ajp.161.12.2163.